These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20167464)

  • 1. Route transition interventions: potential public health gains from reducing or preventing injecting.
    Bridge J
    Int J Drug Policy; 2010 Mar; 21(2):125-8. PubMed ID: 20167464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?
    Dolan K; Clement N; Rouen D; Rees V; Shearer J; Wodak A
    Drug Alcohol Rev; 2004 Sep; 23(3):281-6. PubMed ID: 15370007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public injection settings in Vancouver: physical environment, social context and risk.
    Small W; Rhodes T; Wood E; Kerr T
    Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection.
    Stimson GV
    Bull Narc; 1993; 45(1):3-17. PubMed ID: 8305905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injecting nation: achieving control of hepatitis C in Australia.
    Wodak A
    Drug Alcohol Rev; 1997 Sep; 16(3):275-84. PubMed ID: 16203436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm.
    Rhodes T; Kimber J; Small W; Fitzgerald J; Kerr T; Hickman M; Holloway G
    Addiction; 2006 Oct; 101(10):1384-93. PubMed ID: 16968336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes?
    Brener L; Spooner C; Treloar C
    Int J Drug Policy; 2010 May; 21(3):160-4. PubMed ID: 19427187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young people and drugs: next generation of harm reduction.
    Merkinaite S; Grund JP; Frimpong A
    Int J Drug Policy; 2010 Mar; 21(2):112-4. PubMed ID: 20036526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales.
    Rhodes T; Watts L; Davies S; Martin A; Smith J; Clark D; Craine N; Lyons M
    Soc Sci Med; 2007 Aug; 65(3):572-85. PubMed ID: 17475383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is groin injecting an ethical boundary for harm reduction?
    Miller PG; Lintzeris N; Forzisi L
    Int J Drug Policy; 2008 Dec; 19(6):486-91. PubMed ID: 18024001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
    Panda S; Sharma M
    Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringe exchanges: a public health response to problem drug use.
    Cox GM; Lawless MC; Cassin SP; Geoghegan TW
    Ir Med J; 2000; 93(5):143-6. PubMed ID: 11072923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning from HIV epidemics among injecting drug users.
    Jarlais DC
    Int J Drug Policy; 2010 Mar; 21(2):97-9. PubMed ID: 20018500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
    Lima ES; Bastos FI; Telles PR; Friedman SR
    Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injecting-related injury and disease among clients of a supervised injecting facility.
    Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L
    Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent blue lights, injecting drug use and related health risk in public conveniences: findings from a qualitative study of micro-injecting environments.
    Parkin S; Coomber R
    Health Place; 2010 Jul; 16(4):629-37. PubMed ID: 20167527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the data to strengthen the global response to HIV among people who inject drugs.
    Mathers B; Cook C; Degenhardt L
    Int J Drug Policy; 2010 Mar; 21(2):100-2. PubMed ID: 20144539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The organization of a community: community-based prevention of injecting drug use-related health problems.
    Carruthers S
    Subst Use Misuse; 2007; 42(12-13):1971-7. PubMed ID: 18075921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity.
    Kaye S; Darke S
    Drug Alcohol Rev; 2004 Dec; 23(4):391-8. PubMed ID: 15763743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.